Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

By Palhagen S.   Canger R.   Henriksen O.   van Parys J.A.   Riviere M.-E.   Karolchyk M.A.  

Epilepsy Research, Vol. 43, Iss. 2, 2001-02 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures

By Pietka E.   H. K.H.   Ben-Menachem E.   Soderfelt B.   Hamberger A.   Hedner T.   Persson L.I.  

Epilepsy Research, Vol. 21, Iss. 3, 1995-07 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil

By Saletu M.   Anderer P.   Saletu-Zyhlarz G.   Mandl M.   Arnold O.   Zeitlhofer J.   Saletu B.  

Journal of Neurology, Vol. 251, Iss. 11, 2004-11 ,pp. : 1354-1363

Springer Publishing Company

Access to resources Recommend Favorite

A Randomized, Double-Blind, Placebo-Controlled Trial of Two Doses of Ginkgo Biloba Extract in Dementia of the Alzheimer's Type

By  

Current Alzheimer Research, Vol. 2, Iss. 5, 2005-12 ,pp. : 541-551

Bentham Science Publishers

Access to resources Recommend Favorite